Daiichi Sankyo Company, Limited

Nec Corporation

Koji Suda

Tomio Kimura

Kazumasa Aoki

Toshio Kaneko

Kentoku Gotanda

A pharmaceutical composition comprising a compound having Formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein,

Substituted acrylamide derivative and pharmaceutical composition comprising the same

It is an object of the present invention to provide a substituted propanamide derivative or a pharmacologically acceptable salt thereof that is useful as a prophylactic or therapeutic agent for a bone metabolic disease. The present invention relates to a pharmaceutical composition comprising a compound having General Formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein, Rrepresents a C-Caryl group that may be substituted by a group selected from Substituent Group &#x3b1;, for example; Rrepresents a C-Caryl group that may be substituted by a group selected from Substituent Group &#x3b1;, for example; and X represents a hydroxyl group or a C-Calkoxy group, for example].

Substituted propanamide derivative and pharmaceutical composition containing the same

In a mobile communication system including a switching network and at least one base station operatively connected to the switching network, the base station having a definite number of traffic channels, a memory stores information regarding whether each of the traffic channels is non-free, a data-free or speech-free. A control unit compares information transfer capability included in a call set-up message from one mobile station or to the mobile station with the information of the memory and sets up a call connection between the mobile station and one of the traffic channels in accordance with the result of the comparison.

Growing community of inventors

Tokyo, Japan

Koji Suda